Data

New PROTECT III Data Demonstrates Impella® Reduces MACCE at Primary Endpoint

Top Downloads

Abiomed Cardiogenic Shock Protocol


Presentations

Jeffrey J. Popma, MD, Presents Data from PROTECT III Study

Watch this breakfast symposium presentation featuring data from the 2-year study of high-risk PCI patients supported with Impella and IABP

Protected PCI

SEE ALL

Cardiogenic Shock

SEE ALL

Newsletter

SUBSCRIBE

Upcoming Events


10.18.19
ICE Program Phoenix East
Phoenix, AZ
10.24.19
Management of Patients in Cardiogenic Shock: Appropriate Use of Impella for Support and/or Transport
Detroit, MI
10.28.19
Spectrum Heart Team Implementation Course
Grand Rapids, MI
11.08.19
Dallas Surgical Skills Workshop
Irving, TX
Data

New Data from NCSI Demonstrates 72% Survival with 98% Native Heart Recovery

The patients were treated with the NCSI protocol, which includes placing the Impella heart pump before revascularization

Training

Attend The Complete Revascularization Summit

Interventionalist seeking to better understand complex PCI in the modern era

Presentations

Largest FDA Study of High-Risk PCI Patients Shows Improved Outcomes with Impella® Heart Pumps

Jeffrey J. Popma, MD, presents the latest data from the PROTECT series clinical study

Use our tool to calculate the Mehran Score to estimate a patient's risk of Acute Kidney Injury following a percutaneous coronary intervention bit.ly/30ZvWZ3 pic.twitter.com/u3ir70qcld

From Protected PCI's Twitter

Today, #Impella CP patient, Mary Hanel, celebrated one year of #heartrecovery with her husband, Richard. #PatientsFirst pic.twitter.com/ihaR0DmEOA

From Abiomed's Twitter